COMMUNIQUÉS West-GlobeNewswire

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
24/09/2025
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, [...]
Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique
24/09/2025
Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique Le fonds restera axé sur les [...]
Dimora PHMB Skin and Wound Cleanser - Gentle for Kids, Trusted by Parents
24/09/2025
Dimora PHMB Skin and Wound Cleanser: Gentle for Kids, Trusted by Parents SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Dimora Medical is proud to introduce its newest innovation, the Dimora PHMB Skin and Wound [...]
Press release: Availability of the Q3 2025 Aide mémoire
24/09/2025
Availability of the Q3 2025 Aide mémoire Paris, France – September 24, 2025 . Sanofi announced today that its Q3 2025 Aide mémoire is available on the "Investors" page of the company's website: Third quarter 2025 ( [...]
Communiqué de presse : Mise en ligne du document "Q3 2025 Aide mémoire"
24/09/2025
Mise en ligne du document «Q3 2025 Aide mémoire » Paris, France, le 24 septembre 2025 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q3 2025 Aide [...]
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
24/09/2025
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics”, “Monopar”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative [...]
Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
24/09/2025
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Elevé Cosmetic Surgery Officially Opens in Coral Gables, Accepting a Limited Number of Patients Seeking a Boutique Surgical Experience
24/09/2025
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Elevé Cosmetic Surgery, a new boutique practice in Coral Gables, today announced that it is officially open and accepting a limited number of new patients for facial and [...]
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
24/09/2025
WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“ Mural ”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover [...]
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
23/09/2025
HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development for infectious [...]
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/09/2025
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September [...]
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
23/09/2025
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company’s supplemental New [...]
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
23/09/2025
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
23/09/2025
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) acknowledges the decision [...]
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
23/09/2025
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes NANTES, France – 23 septembre 2025, 22 h 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) prend acte de la décision [...]
Nyxoah Provides an Update on Expanded Middle East Presence
23/09/2025
Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025 Mont-Saint-Guibert, Belgium – September 23, 2025, 10: [...]
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient
23/09/2025
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient De nouveaux centres à Dubaï, au Koweït et à Abu Dhabi après la première implantation de Genio® dans la région au début de l'année 2025 Mont [...]
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
23/09/2025
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
23/09/2025
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]

Pages